NCT05609955View on ClinicalTrials.gov

Effects Of Additional MgSO4 30 Mg/KgBW Intravenous and Ketorolac

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

October 1, 2022

Study Completion Date

November 1, 2022

Conditions
AnesthesiaPain, PostoperativeSurgeryOpioid Use
Interventions
DRUG

MgSO4

The treatment group who received intravenous magnesium sulfate therapy with 20% magnesium sulfate regimen, 30mg/kg body weight dissolved in 100ml NaCl in 1 hour intravenously

Trial Locations (1)

10430

Cipto Mangunkusumo Cental National Hospital, Jakarta

All Listed Sponsors
lead

Indonesia University

OTHER

NCT05609955 - Effects Of Additional MgSO4 30 Mg/KgBW Intravenous and Ketorolac | Biotech Hunter | Biotech Hunter